ZYME
Zymeworks Inc.
NASDAQ · Healthcare · Biotechnology · CA
$25.54
+2.04%Leverage
- Debt / equity
- 3.34x
- Net debt / equity
- 1.11x
- Debt / assets
- 0.68x
- Debt / EBITDA
- -1.92x
- Net debt / EBITDA
- -0.64x
Liquidity & coverage
- Current ratio
- 6.32x
- Quick ratio
- 6.32x
- Cash ratio
- 5.73x
- Interest coverage
- -75.30x
- EBITDA / interest
- -67.88x
- Working capital
- $251.1M
Cash & dividend
- FCF / debt
- -0.45x
- Cash flow / debt
- -0.44x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026